TSXV:TRL.H - Post by User
Comment by
eSnowdenon Nov 24, 2015 9:29am
135 Views
Post# 24319154
RE:Rossi
RE:Rossi
Here is the nightmare scenario. Endo ends the Natesto contract with Acerus and wants the $25mm payment returned, thus leaving Acerus with no cash. Then the Midcap Financial loan repayment of $20mm begins (along with Ian's First Generation $25mm loan)--money we used to purchase Estrace. If there is a slight silver lining is that Rossi did a 30million share dilution for $18mm in acqurirng Estrace. Now who they paid with those monies to is a mystery...it leaves $27mm outstanding. With a free-falling share price, financing is out of the question. I honestly don't know where they can turn.
Now as for Rossi, the first question before plunking down $45mm for Estrace is "when do the patents expire" If he knew that it would become generic in less than a year and a half time--he should be walking the gang plank. If not, then he was misled and be looking to Shire to get some money returned.